A once-scrapped Alzheimer’s drug may work after all, new analyses suggest
An antibody that targets Alzheimer’s sticky protein amyloid showed promise in slowing mental decline, according to the company that’s developing it.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
